Joi Women’s Wellness, presented within Joi + Blokes, offers clinician-led menopause care. The public offer reviewed here is nevertheless centered on hormone therapy. For someone specifically seeking nonhormonal help, that distinction is the central finding rather than a detail to gloss over: a relevant clinical service is not automatically a verified offer of a particular alternative medicine.
This September 29, 2026 review considers the service overview and hormone-program page. It does not conclude that Joi never discusses nonhormonal care; it records that the reviewed offer does not establish a specific systemic nonhormonal menopause prescription. The questions concern service fit, professional roles, evidence and the financial terms of the program actually described.
Verify the clinical service without inventing another catalog
The Joi + Blokes homepage describes review of a medical history by partner providers, who determine whether a prescription is appropriate. Menopause is explicitly part of its scope. That supports a provider review, but does not supply a list of nonhormonal hot-flash medicines. Our Wisp assessment shows another reason to be precise: a specific hormone-free local product does not establish a systemic vasomotor offer. At Joi, the first question is even earlier. Can the relevant clinician assess the particular goal without assuming that the visitor wants the hormone program presented on the page?
The desired outcome should be stated before the program is selected
Joi’s hormone-program description discusses several hormonal preparations and ongoing adjustment of care. Those details cannot be repurposed into a nonhormonal treatment plan simply because a visitor prefers to avoid estrogen or progesterone. The visit-goals guide helps separate the concern from a preselected solution. A prospective patient can ask whether the service evaluates that concern, what nonhormonal categories it actually offers and whether another clinical setting would be needed. This review has not obtained those individual answers. The existence of a clinician does not make every treatment family part of the confirmed public menu.
A coach’s helpful role is different from medical authority
The homepage FAQ describes health coaches as a contact point who can support communication and provide general information. It explicitly says coaches cannot diagnose, prescribe or provide specific medical advice. That limitation is useful when interpreting an offer of continued support. A question about whether a medicine fits a medical history belongs with the responsible clinician; a coach’s availability does not independently answer it. The FOLX review examines a service with both clinical and community components. In either setting, identifying the role behind a reply matters more than counting the number of ways to contact the platform.
Wellness categories do not share one hot-flash evidence base
Joi’s service overview includes diagnostics, supplements and coaching alongside prescriptions. The 2023 nonhormone position-statement abstract evaluates options for vasomotor symptoms and does not recommend supplements or herbal remedies for that purpose. That scoped conclusion does not decide every reason a clinician might discuss nutrition or another product. It does prevent a general wellness category from being treated as demonstrated hot-flash therapy. The medicine-family guide keeps those distinctions visible. A product’s presence in the same storefront as clinical care is not evidence that it treats the particular symptom a reader wants assessed. Our Stella review similarly separates a clinical menu from coaching and app resources, rather than assigning one evidence claim to all three.
The published care fee describes the hormone program
The HRT page states $50 per month billed quarterly for ongoing care, with medicines billed separately and everything shipping and billing quarterly. It says cancellation is available after the first three months. The page’s initial laboratory options are displayed at $149, $399 and $699, while its care descriptions variously refer to included labs and follow-up labs. Those details should be clarified for a selected arrangement rather than combined into an invented total. They are hormone-program prices, not a verified quote for nonhormonal care. The homepage’s zero-membership and zero-consultation presentation does not erase the separate recurring care charge on this specific offer. The program also has a more general cancel-anytime statement elsewhere on the page. That should be read alongside the first-three-month qualification, not substituted for it. Ask which condition governs the selected arrangement and what has already been committed when care starts. No arithmetic based on a monthly display can establish an unverified cancellation or refund entitlement.
A pharmacy insurance possibility is not a clinical benefit determination
Joi’s public explanation says it does not bill insurance directly, while certain prescriptions may be sent to a local pharmacy for possible use of benefits. That does not establish coverage for an unidentified nonhormonal medicine or for the clinician’s services. The program page also contains separate product and shipping conditions that should not be generalized across every possible treatment. Obtain a quote tied to the actual proposal, including care, testing and medicine charges. We have not verified a state-specific appointment, benefit determination, selected cancellation agreement or refund. US-only service language is not a personal access confirmation.
An unanswered fit question is a legitimate review conclusion
Joi’s clinical pathway is documented, while the requested nonhormonal menu remains unconfirmed in the reviewed pages. The useful next clarification is whether the service can assess the particular concern and, if so, which treatment family and responsible professional would be involved. FDA’s off-label explanation also shows why any later proposal needs its actual medicine and intended use identified. This assessment neither recommends the hormone program nor fills its gaps with another provider’s nonhormonal offering. It reports a real menopause service with an important unresolved fit question, rather than transforming broad wellness language into a product or outcome claim.
Follow the evidence
Source documents
Read each source for the product, population and purpose it describes. Commercial pages document advertised terms, not individual care outcomes.
- Joi + Blokes: Clinical care overviewOfficial menopause clinical service and coaching roles; no specific nonhormonal vasomotor prescription confirmed · Checked 2026-09-29
- Joi + Blokes: Hormone replacement therapyHormonal program prices and quarterly commitments; not a confirmed nonhormonal medicine menu or quote · Checked 2026-09-29
- The Menopause Society: 2023 nonhormone therapy position statementPubMed primary professional abstract; vasomotor-symptom evidence categories, dated 2023 and not provider-specific efficacy or later-drug approval · Checked 2026-09-29
- FDA: Understanding unapproved use of approved drugsFederal explanation distinguishing an approved medicine from an unapproved use; not a personal recommendation · Checked 2026-09-29